Events
Resources
About us
Capabilities
Capabilities
Overview
Biologics
Drug device combinations
Sterile Injectables
Soft gelatin capsules
Facilities
Overview
Integrated DS & DP Facility
Global R&D Facility
Sterile Injectable Facility
Penicillin Injectable Facility
Soft Gelatin Facility
Regulatory & Quality
Regulatory services
Quality
Investors relations
Overview
Financial reports
Shareholder information
Corporate governance
Press releases
Stock exchange intimation
Disclosures under regulation 46 LODR
Scheme of arrangement 2024
Scheme of arrangements 2025
Policies
Careers
Working at OneSource
Notice to Job Seekers
News room
Press releases
Contact us
Events
Resources
Scheme of arrangements 2025
Scheme of arrangements 2025
Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption)
06 Mar 2026 – Update on Composite Scheme of Arrangement and Amalgamation (Merger by Absorption)
Observation letter from BSE and NSE
26 Feb 2026 – Observation letter from BSE and NSE
Complaints Report
NSE Compliants Report
BSE Complaints Report
Draft Scheme of arrangement
Scheme of Arrangement
Valuation Report
Valuation Report Signed
Fairness Opinion
Fairness Opinion – ICICI Securities
Undertaking from OneSource Specialty Pharma Limited
Undertaking for valuation
Report from the Audit Committee
OneSource_Audit Committee Report
Report from the Committee of Independent Directors
OneSource_ID Report
Pre and post amalgamation shareholding pattern of Unlisted entities
SHP of Unlisted Companies
Audited financials of Unlisted entities
Financial Summary
Statutory Auditor Certificate
Statutory Auditors Certificate
Compliance Report
Compliance Report
Declaration on past defaults of listed debt obligations
Declaration for past defaults
NOC from Lenders
Undertaking from Lenders
Stay informed
Don’t miss out on the latest news, results and key updates from OneSource.
Email
(Required)